Literature DB >> 29637533

Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.

Naohiro Aruga, Hiroshi Kijima1, Ryota Masuda, Hiroto Onozawa, Tadashi Yoshizawa, Makiko Tanaka, Sadaki Inokuchi, Masayuki Iwazaki.   

Abstract

Epithelial-mesenchymal transition (EMT) is an important step leading to invasion and migration of various cancer cells, and are characterized by decreased E-cadherin as an epithelial marker, and increased vimentin as a mesenchymal marker. The present study focused on the clinicopathological significance of E-cadherin and vimentin expression in lung squamous cell carcinoma (SqCC). Immunohistochemically, E-cadherin expression patterns were classified into two types: preserved or reduced; and vimentin expression patterns were also divided into two types: positive or negative. The univariate analyses showed six factors associated with increased mortality: tumor size (P = 0.031), lymph node metastasis (P < 0.001), lymphatic invasion (P < 0.001), histological differentiation (P = 0.036), E-cadherin reduced expression (P < 0.001), and vimentin positive expression (P = 0.004). Multivariate analysis demonstrated that E-cadherin reduced expression (P < 0.001), vimentin positive expression (P = 0.028), lymph node metastasis (P < 0.001), and age (P = 0.020) were independent predictors of patient mortality. There may be some correlation between E-cadherin and vimentin expression (P = 0.017), but the correlation coefficient was 0.235. The complete EMT and the incomplete EMT type were associated with a poor prognosis (p < 0.001 and p=0.036, respectively). The overall survival rate after curative resection was significantly lower in patients with the complete EMT type (reduced E-cadherin / positive vimentin). In conclusion, both E-cadherin and vimentin are independent predictors of mortality, and the EMT phenotype is a significant indicator of poor prognosis in lung SqCC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29637533

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  9 in total

1.  Influence of buffy coat-derived putative endothelial progenitor cells on tumor growth and neovascularization in oral squamous cell carcinoma xenografts.

Authors:  Marius Otto; Sebastian Blatt; Andreas Pabst; Robert Mandic; Johanna Schwarz; Andreas Neff; Thomas Ziebart
Journal:  Clin Oral Investig       Date:  2019-01-28       Impact factor: 3.573

Review 2.  EMT and Inflammation: Crossroads in HCC.

Authors:  Burcu Sengez; Brian I Carr; Hani Alotaibi
Journal:  J Gastrointest Cancer       Date:  2022-01-12

Review 3.  Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma.

Authors:  Mortaza Raeisi; Leila Hassanbeigi; Fatemeh Khalili; Hengameh Kharrati-Shishavan; Mehdi Yousefi; Amir Mehdizadeh
Journal:  Mol Biol Rep       Date:  2022-07-29       Impact factor: 2.742

4.  Emergence of Resistance to MTI-101 Selects for a MET Genotype and Phenotype in EGFR Driven PC-9 and PTEN Deleted H446 Lung Cancer Cell Lines.

Authors:  Clark Jones; Sebastian Dziadowicz; Samuel Suite; Ashley Eby; Wei-Chih Chen; Gangqing Hu; Lori A Hazlehurst
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

5.  Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition.

Authors:  Yu Tao; Liu Fei; Liu Chang; Liu Yongyu; Jia Jianhui; Liu Yanan; Ren Yi
Journal:  Genes Genomics       Date:  2021-06-04       Impact factor: 1.839

6.  A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker.

Authors:  Louis Godin; Cédric Balsat; Yves-Rémi Van Eycke; Justine Allard; Claire Royer; Myriam Remmelink; Ievgenia Pastushenko; Nicky D'Haene; Cédric Blanpain; Isabelle Salmon; Sandrine Rorive; Christine Decaestecker
Journal:  Cancers (Basel)       Date:  2020-04-08       Impact factor: 6.639

7.  Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma.

Authors:  Sivasundaram Karnan; Akinobu Ota; Hideki Murakami; Md Lutfur Rahman; Muhammad Nazmul Hasan; Md Wahiduzzaman; Ichiro Hanamura; Lam Quang Vu; Akihito Inoko; Toshinori Hyodo; Hiroyuki Konishi; Shinobu Tsuzuki; Yoshitaka Hosokawa
Journal:  Cell Death Discov       Date:  2020-11-18

8.  In Vitro Suppression of T Cell Proliferation Is a Conserved Function of Primary and Immortalized Human Cancer-Associated Fibroblasts.

Authors:  Mohammed H Abuwarwar; Alfie T Baker; Jeffrey Harding; Natalie L Payne; Andras Nagy; Konstantin Knoblich; Anne L Fletcher
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

9.  LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer.

Authors:  Masato Kamakura; Takeshi Uehara; Mai Iwaya; Shiho Asaka; Shota Kobayashi; Tomoyuki Nakajima; Yasuhiro Kinugawa; Tadanobu Nagaya; Takahiro Yoshizawa; Akira Shimizu; Hiroyoshi Ota; Takeji Umemura
Journal:  Diagn Pathol       Date:  2022-02-05       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.